129 related articles for article (PubMed ID: 7923587)
1. Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens.
Penman BW; Chen L; Gelboin HV; Gonzalez FJ; Crespi CL
Carcinogenesis; 1994 Sep; 15(9):1931-7. PubMed ID: 7923587
[TBL] [Abstract][Full Text] [Related]
2. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
[TBL] [Abstract][Full Text] [Related]
3. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
Sengstag C; Eugster HP; Würgler FE
Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.
Tsyrlov IB; Goldfarb IS; Gelboin HV
Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012
[TBL] [Abstract][Full Text] [Related]
5. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
7. Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2.
Macé K; Gonzalez FJ; McConnell IR; Garner RC; Avanti O; Harris CC; Pfeifer AM
Mol Carcinog; 1994 Oct; 11(2):65-73. PubMed ID: 7916994
[TBL] [Abstract][Full Text] [Related]
8. Stable expression of human cytochrome P450 1A1 cDNA in V79 Chinese hamster cells and metabolic activation of benzo[a]pyrene.
Schmalix WA; Mäser H; Kiefer F; Reen R; Wiebel FJ; Gonzalez F; Seidel A; Glatt H; Greim H; Doehmer J
Eur J Pharmacol; 1993 Oct; 248(3):251-61. PubMed ID: 8293790
[TBL] [Abstract][Full Text] [Related]
9. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ
Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407
[TBL] [Abstract][Full Text] [Related]
10. Interferon-mediated changes in the expression of CYP1A1 in human B lymphoblastoid (AHH-1 TK +/-) cells.
Delaporte E; Cribb AE; Renton KW
Can J Physiol Pharmacol; 1995 Dec; 73(12):1692-7. PubMed ID: 8834482
[TBL] [Abstract][Full Text] [Related]
11. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1.
Lautraite S; Musonda AC; Doehmer J; Edwards GO; Chipman JK
Mutagenesis; 2002 Jan; 17(1):45-53. PubMed ID: 11752233
[TBL] [Abstract][Full Text] [Related]
13. A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing.
Crespi CL; Gonzalez FJ; Steimel DT; Turner TR; Gelboin HV; Penman BW; Langenbach R
Chem Res Toxicol; 1991; 4(5):566-72. PubMed ID: 1793807
[TBL] [Abstract][Full Text] [Related]
14. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3.
Crespi CL; Penman BW; Steimel DT; Gelboin HV; Gonzalez FJ
Carcinogenesis; 1991 Feb; 12(2):355-9. PubMed ID: 1899812
[TBL] [Abstract][Full Text] [Related]
15. Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1.
Crespi CL; Steimel DT; Aoyama T; Gelboin HV; Gonzalez FJ
Mol Carcinog; 1990; 3(1):5-8. PubMed ID: 2108694
[TBL] [Abstract][Full Text] [Related]
16. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.
Eugster HP; Probst M; Würgler FE; Sengstag C
Drug Metab Dispos; 1993; 21(1):43-9. PubMed ID: 8095225
[TBL] [Abstract][Full Text] [Related]
17. Transfection of a human cytochrome P-450 gene into the human lymphoblastoid cell line, AHH-1, and use of the recombinant cell line in gene mutation assays.
Crespi CL; Langenbach R; Rudo K; Chen YT; Davies RL
Carcinogenesis; 1989 Feb; 10(2):295-301. PubMed ID: 2912581
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
19. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.
Crespi CL; Penman BW; Gelboin HV; Gonzalez FJ
Carcinogenesis; 1991 Jul; 12(7):1197-201. PubMed ID: 2070484
[TBL] [Abstract][Full Text] [Related]
20. Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s.
Styles JA; Davies A; Lim CK; De Matteis F; Stanley LA; White IN; Yuan ZX; Smith LL
Carcinogenesis; 1994 Jan; 15(1):5-9. PubMed ID: 8293548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
